62% is a big percentage. More proof olive oil is a good addition to all of our diets:
I apologize for not posting more here at HWC; I recently traveled to Iowa City to undergo a stem cell transplant at the University of Iowa Cancer Center.
The researchers involved call this breakthrough a “game-changer for drug development.” The applications in oncology are countless:
I just heard from a consulting company I’ve worked with in the past. They are offering $100 for anyone that has–or has had–head or neck cancer to take a short survey over the phone.
Good news. $10,000,000 can make a real difference when its focused like this. I can’t think of a more important area to research.
Many of us watched with hopeful wonder as 60 Minutes reported on an innovative biologic solid tumor cancer therapy Sunday evening. But is it as good as it seems?
If only it could be this easy: using specially designed nano tubes to help diagnose and battle cancer; a twofer!
Reading this, I’m reminded of imagining flying cars and jet packs back when I was a kid. How can British scientists arbitrarily pick a date like 2050 for the eradication of cancer?
I’ve been seeing this news all over the internet. I’m concerned that the study size was too small (18), and the model and executions were flawed. Still, the premise makes perfect sense:
Its been almost seven years since I was diagnosed with bone marrow cancer. I’ve been receiving ongoing treatment ever since.
Easy to follow explanation for why drug prices are so high in United States as compared to other countries. Here are several excerpts from this important Medscape Today article:
Monday I wrote an important post about a 60 Minutes report that focused on the unreasonably high cost of chemotherapy drugs. Here’s the link:
Know how sometimes you save something, thinking you may need it in the future? Pattie and I are going through that a lot these days, having recently moved across Florida into a home we’re renovating on Florida’s East Coast.
This is exciting news. Not so much because of this specific new drug. But because of what it represents: cancer immunotherapy is becoming a reality.
I noticed this article about statins and cancer after hearing from a fellow multiple myeloma patient earlier this week. Apparently, using statins can help limit the ruinous effects of long term dexamethasone use, a common myeloma therapy.
Are Western medical researchers finally starting to catch up with their Eastern counterparts by using compounds occurring in nature to help cure cancer?
Individualized medicine is the hot catchphrase these days. But what about individualized dosing? Prompted by fellow myeloma patient and researcher, Gary Blau, I have been advocating more attention be paid to maximizing the timing and effectiveness of existing drugs.
Here’s a short excerpt from a fascinating article that just ran on MedicalXpress.com about drug resistance in cancer cells:
How’s this for some exciting research news:
The mainstream media has embraced palbociclib, a new breast cancer drug that may work against a number of other cancers, too. Early reports broke on business websites. This is to be expected. After all, hope helps stock soar.